Form 4: Definitive Healthcare Corp. Executive William Moschella Reports Share Transaction

Chief Product & Tech Officer of Definitive Healthcare Corp., William Moschella, reports a transaction involving the withholding of 13,421 shares to cover tax obligations.

Summary

• William Moschella, Chief Product & Tech Officer at Definitive Healthcare Corp., has reported a transaction involving company stock.
• The transaction occurred on January 1, 2025, and involved the withholding of 13,421 Class A Common Stock shares.
• These shares were withheld by the issuer to cover Moschella's tax obligations related to the vesting of restricted stock units.
• The price per share for the transaction was $4.11.
• Following the transaction, Moschella directly owns 420,409 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not indicate any positive or negative sentiment. It is a neutral transaction related to executive compensation.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is typical for executives receiving stock-based compensation.
• Similar filings can be seen across the technology and healthcare sectors where stock-based compensation is a common practice.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it is a standard tax withholding event.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transaction, Definitive Healthcare Corp, William Moschella, Tax Withholding, Restricted Stock Units